Published in Eur Urol on January 17, 2006
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med (2009) 2.12
In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. BMC Mol Biol (2007) 1.93
Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer. J Natl Cancer Inst (2013) 1.60
FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis. Cancer Cell (2010) 1.58
Solid renal masses in adults. Indian J Radiol Imaging (2017) 1.39
Retracted Collecting duct carcinoma of the kidney: a clinicopathological study of five cases. Diagn Pathol (2013) 1.38
Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Mol Cancer Ther (2014) 1.21
SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer. Cancer Cell (2014) 1.11
Tissue-based research in kidney cancer: current challenges and future directions. Clin Cancer Res (2008) 1.07
Papillary renal cell carcinoma within a renal oncocytoma: Case report of very rare coexistence. Can Urol Assoc J (2014) 1.07
PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am J Surg Pathol (2010) 1.06
Type 2 diabetes and the risk of renal cell cancer in women. Diabetes Care (2011) 1.05
Renal cell carcinoma in India demonstrates early age of onset & a late stage of presentation. Indian J Med Res (2014) 1.04
Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras (2015) 1.03
Pelvic nephroureterectomy for renal cell carcinoma in an ectopic kidney. Case Rep Oncol Med (2012) 1.02
p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets? Cancer (2010) 1.00
Epigenetic regulation in RCC: opportunities for therapeutic intervention? Nat Rev Urol (2012) 0.99
Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype. Radiol Oncol (2014) 0.98
Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent. BMC Cancer (2010) 0.95
TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas. Oncotarget (2014) 0.94
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies. Ann Oncol (2014) 0.94
Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors. PLoS One (2010) 0.93
ABO blood group and risk of renal cell cancer. Cancer Epidemiol (2012) 0.93
Renal mucinous tubular and spindle cell carcinoma: a report of 8 cases and review of the literature. Diagn Pathol (2013) 0.91
Renal carcinoma after childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst (2013) 0.91
Mucinous tubular and spindle cell carcinoma of the kidney: a case report. Case Rep Oncol (2012) 0.91
Functional significance of erythropoietin in renal cell carcinoma. BMC Cancer (2013) 0.91
Clinical and computed tomography imaging features of renal medullary carcinoma: A report of six cases. Oncol Lett (2015) 0.91
Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study. Ann Surg Oncol (2012) 0.90
Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer (2009) 0.90
A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma. J Cancer Res Clin Oncol (2015) 0.90
Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol (2016) 0.89
Renal collision tumour of papillary cell carcinoma and chromophobe cell carcinoma with sarcomatoid transformation: A case report and review of the literature. Can Urol Assoc J (2014) 0.88
A divide-and-conquer strategy in tumor sampling enhances detection of intratumor heterogeneity in routine pathology: A modeling approach in clear cell renal cell carcinoma. F1000Res (2016) 0.88
Papillary renal cell carcinoma embedded in an oncocytoma: Case report of a rare combined tumour of the kidney. Can Urol Assoc J (2013) 0.87
The Prognostic Factors for Patients with pT1a Renal Cell Carcinoma. Korean J Urol (2010) 0.87
MRI phenotype in renal cancer: is it clinically relevant? Top Magn Reson Imaging (2014) 0.86
Treatment of renal angiomyolipoma: surgery versus angioembolization. G Chir (2013) 0.85
A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use. World J Urol (2016) 0.85
Coexistent loss of INI1 and BRG1 expression in a rhabdoid renal cell carcinoma (RCC): implications for a possible role of SWI/SNF complex in the pathogenesis of RCC. Int J Clin Exp Pathol (2014) 0.84
Clinical outcome of patients with pancreatic metastases from renal cell cancer. BMC Cancer (2015) 0.84
Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features. Int J Clin Exp Pathol (2013) 0.83
Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses. World J Urol (2010) 0.82
VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients. Int J Clin Exp Pathol (2014) 0.82
Mucinous tubular and spindle cell carcinoma of the kidney: A case report and review of the literature. Oncol Lett (2014) 0.82
Epigenetic regulation of thyroid hormone receptor beta in renal cancer. PLoS One (2014) 0.82
Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion. PLoS One (2014) 0.82
Sarcomatoid renal cell carcinoma: a case report and literature review. J Radiol Case Rep (2012) 0.82
Temsirolimus in the treatment of renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion proteins: a case report and review of literature. Rare Tumors (2009) 0.82
Cannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma. J Histochem Cytochem (2010) 0.81
The epigenetic landscape of renal cancer. Nat Rev Nephrol (2016) 0.81
The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy. Biomed Res Int (2015) 0.81
Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article. Medicine (Baltimore) (2015) 0.80
Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population. Sci Rep (2016) 0.80
DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas. Clin Cancer Res (2016) 0.80
TGF-β1 expression in chromophobe renal cell carcinoma and renal oncocytoma. Eur J Histochem (2014) 0.80
Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma. Oncotarget (2014) 0.80
Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas. Sci Rep (2016) 0.79
TFE3 Translocation-Associated Renal Cell Carcinoma Presenting as Avascular Necrosis of the Femur in a 19-Year-Old Patient: Case Report and Review of the Literature. Case Rep Med (2011) 0.79
Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma. Br J Cancer (2013) 0.79
Can renal oncocytoma be distinguished from chromophobe renal cell carcinoma by the presence of fibrous capsule? Virchows Arch (2009) 0.79
Renal cell carcinoma with t(6:11) (p21;q12). A case report highlighting distinctive immunohistologic features of this rare tumor. Int J Surg Case Rep (2014) 0.79
The ineligible patient: how to treat patients not included in clinical studies. World J Urol (2013) 0.78
Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component. J Cancer Res Clin Oncol (2013) 0.78
Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target? Oncologist (2012) 0.78
Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas. Korean J Urol (2015) 0.78
Fewer complications after laparoscopic nephrectomy as compared to the open procedure with the modified Clavien classification system--a retrospective analysis from southern China. World J Surg Oncol (2014) 0.78
Mucinous tubular and spindle cell carcinoma of the kidney: imaging features. Cancer Imaging (2012) 0.77
Comparative study of CT appearances in mucinous tubular and spindle cell carcinoma and collecting duct carcinoma of the kidney. Br J Radiol (2015) 0.77
Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol. BMJ Open (2016) 0.77
Clinicopathological features of Xp11.2 translocation renal cell carcinoma. Korean J Urol (2015) 0.77
Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria. Virchows Arch (2012) 0.77
The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma. J Cancer Res Clin Oncol (2012) 0.77
Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma. Int J Clin Exp Pathol (2014) 0.77
Imaging of Solid Renal Masses. Radiol Clin North Am (2016) 0.77
Use of DWI in the Differentiation of Renal Cortical Tumors. AJR Am J Roentgenol (2016) 0.77
Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors. Diagn Pathol (2008) 0.77
Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients. PLoS One (2015) 0.76
Imaging hallmark of Xp11.2 translocation renal cell carcinoma. Can Urol Assoc J (2015) 0.76
Clear cell papillary renal cell carcinoma: a potential mimic of conventional clear cell renal carcinoma on core biopsy. Case Rep Urol (2015) 0.76
Collecting duct carcinoma of the kidney: Imaging observations of a rare tumor. Oncol Lett (2013) 0.76
Malignant renal epithelioid angiomyolipoma: A case report and review of the literature. Oncol Lett (2015) 0.76
Renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion: imaging findings in 21 patients. Eur Radiol (2016) 0.75
Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma. J Cancer (2016) 0.75
Unclassified renal cell carcinoma: a clinicopathological, comparative genomic hybridization, and whole-genome exon sequencing study. Int J Clin Exp Pathol (2014) 0.75
Unclassified mucinous renal cell carcinoma: a rare histopathological entity. Korean J Urol (2014) 0.75
Preoperative serum docosahexaenoic acid level predicts prognosis of renal cell carcinoma. Mol Clin Oncol (2016) 0.75
Altered glutamyl-aminopeptidase activity and expression in renal neoplasms. BMC Cancer (2014) 0.75
Histological and immunohistochemical characterization of feline renal cell carcinoma: a case series. J Vet Med Sci (2016) 0.75
Clinicopathological study on thyroid follicular carcinoma-like renal tumor related to serious hypertension: Case report and review of the literature. Medicine (Baltimore) (2017) 0.75
Downregulation of a novel long non-coding RNA, LOC389332, is associated with poor prognosis and tumor progression in clear cell renal cell carcinoma. Exp Ther Med (2017) 0.75
Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy. PLoS One (2017) 0.75
Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer. Dis Markers (2016) 0.75
Expression of claudin-1 and -7 in clear cell renal cell carcinoma and its clinical significance. Korean J Urol (2011) 0.75
Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma. Oncotarget (2016) 0.75
Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization. BJU Int (2014) 0.75
Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases. BMC Cancer (2017) 0.75
A Four-Year Follow-up Study of Renal Epithelioid Angiomyolipoma: A Multi-Center Experience and Literature Review. Sci Rep (2015) 0.75
Prognostic significance of perirenal infiltration in renal cell carcinoma (<7 cm). Yonsei Med J (2012) 0.75
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science (2012) 3.74
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol (2013) 3.68
The use of morphological characteristics and texture analysis in the identification of tissue composition in prostatic neoplasia. Hum Pathol (2004) 2.94
Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complications. Eur Urol (2009) 2.76
Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group. Eur Urol (2009) 2.71
Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity? Eur Urol (2007) 2.33
The contemporary concept of significant versus insignificant prostate cancer. Eur Urol (2011) 2.29
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genet (2013) 2.29
Immunoglobulin G4-related disease in genitourinary organs: an emerging fibroinflammatory entity often misdiagnosed preoperatively as cancer. Eur Urol (2012) 2.18
Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies. Am J Surg Pathol (2010) 2.16
The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol (2013) 2.05
Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol (2012) 2.05
Words of wisdom: re: multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Eur Urol (2013) 2.00
Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin Cancer Res (2005) 1.90
Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol (2007) 1.82
ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease. Eur Urol (2011) 1.80
Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors. Eur Urol (2010) 1.79
Toxicities of targeted therapy and their management in kidney cancer. Eur Urol (2011) 1.76
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens. Am J Surg Pathol (2008) 1.72
Emergency department visits, use of imaging, and drugs for urolithiasis have increased in the United States. Kidney Int (2013) 1.72
Neuroendocrine tumours of the urinary system and male genital organs: clinical significance. BJU Int (2009) 1.71
The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol (2011) 1.71
Multilocular cystic renal cell carcinoma : a report of 45 cases of a kidney tumor of low malignant potential. Am J Clin Pathol (2006) 1.69
Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials. Eur Urol (2010) 1.60
Evidence for common clonal origin of multifocal lung cancers. J Natl Cancer Inst (2009) 1.59
ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol (2011) 1.59
A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens. Eur Urol (2012) 1.56
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl (2005) 1.54
The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens. Hum Pathol (2007) 1.53
Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. Hum Pathol (2007) 1.52
Original Gleason system versus 2005 ISUP modified Gleason system: the importance of indicating which system is used in the patient's pathology and clinical reports. Eur Urol (2010) 1.51
Molecular pathology of lung cancer: key to personalized medicine. Mod Pathol (2012) 1.50
Expression of COX-2 in normal and pyelonephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma. Eur Urol (2006) 1.50
Carcinogenesis and the hypothesis of phylogenetic reversion. Anal Quant Cytol Histol (2006) 1.47
The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC Urol (2014) 1.47
Plasmacytoid urothelial carcinoma of the bladder. Hum Pathol (2009) 1.46
2009 update on the classification of renal epithelial tumors in adults. Int J Urol (2009) 1.43
What does the urologist expect from the pathologist (and what can the pathologists give) in reporting on adult kidney tumour specimens? Eur Urol (2006) 1.42
Immunohistochemical expression of endothelin-1 and endothelin-A and endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer. Eur Urol (2007) 1.39
Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy. Virchows Arch (2007) 1.39
Rare and unusual histological variants of prostatic carcinoma: clinical significance. BJU Int (2008) 1.36
Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences. Eur Urol (2008) 1.35
Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol (2010) 1.33
Current management of renal cell carcinoma and targeted therapy. Urol J (2006) 1.33
Histologic grading of noninvasive papillary urothelial neoplasms. Eur Urol (2006) 1.29
The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma. Int J Cancer (2010) 1.29
Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature. Eur Urol (2010) 1.28
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. Diagn Pathol (2014) 1.26
Lymphoepithelioma-like carcinoma of the prostate. Hum Pathol (2009) 1.26
Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol (2009) 1.24
Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol (2009) 1.24
Inflammatory myofibroblastic tumors of the genitourinary tract--single entity or continuum? J Urol (2008) 1.22
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol (2010) 1.22
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol (2010) 1.22
Frequent FGFR3 mutations in urothelial papilloma. J Pathol (2002) 1.21
Staging of prostate cancer. Histopathology (2012) 1.19
Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol (2010) 1.19
Contemporary management of small renal masses. Eur Urol (2011) 1.19
ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology. Eur Urol (2012) 1.19
Ureteral endometriosis: clinicopathological and immunohistochemical study of 7 cases. Hum Pathol (2008) 1.19
Basic research in kidney cancer. Eur Urol (2011) 1.19
Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res (2007) 1.18
Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol (2013) 1.17
Cystic lesions of the prostate gland: an ultrasound classification with pathological correlation. J Urol (2008) 1.16
Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Am J Clin Pathol (2004) 1.16
Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations. Am J Surg Pathol (2013) 1.15
Germ cell origin of testicular carcinoid tumors. Clin Cancer Res (2008) 1.15
Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate. Mod Pathol (2006) 1.15
A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer. Eur Urol (2009) 1.13
Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? Arch Pathol Lab Med (2012) 1.12
Current pathology keys of renal cell carcinoma. Eur Urol (2011) 1.11
Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol (2011) 1.11
Handling and pathology reporting of prostate biopsies. Eur Urol (2004) 1.11
Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation. Am J Surg Pathol (2011) 1.11
Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry. J Clin Pathol (2006) 1.10
Protocol for the examination of specimens from patients with carcinoma of the prostate gland. Arch Pathol Lab Med (2009) 1.10
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins. Mod Pathol (2010) 1.09
Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder. Clin Cancer Res (2007) 1.09
Solitary fibrous tumour of the prostate identified on needle biopsy. Eur Urol (2009) 1.09